معرفی
Dong-Hyun Kim, PhD, is a Professor at the Feinberg School of Medicine and McCormick School of Engineering at Northwestern University. His research focuses on developing therapeutic micro/nanoparticles for cancer treatment, including drug delivery, hyperthermia, immunotherapy, and molecular imaging. He collaborates with clinicians, biologists, and imaging professionals to translate multifunctional carriers into clinical applications.
Education:
- PhD: Yonsei University College of Medicine, Korea (2006)
- Postdoctoral Fellow: University of Alabama, Chemical & Biological Engineering (2008)
- Postdoctoral Fellow: Argonne National Laboratory, Materials Science Division (2011)
Research Interests:
- Therapeutic carriers for cancer treatment (e.g., nanoparticles, microspheres)
- Interventional oncology and targeted drug delivery
- Immunotherapy integration with nanotechnology
- Diagnostic imaging (MRI, CT, ultrasound) for treatment monitoring
- Translational research bridging lab and clinical applications
Key Trends in Publications: Recent work emphasizes CRISPR-mediated genome editing, ferroptosis-inducing nanoparticles, cryo-immunotherapy, and radiomics for tumor assessment. Articles highlight synergy between nanotechnology and immunotherapy, with a focus on liver, prostate, and pancreatic cancers.
Affiliations:
- Northwestern University Clinical and Translational Sciences Institute (NUCATS)
- Robert H. Lurie Comprehensive Cancer Center
Labs/Teams: Active in multidisciplinary teams developing nanomedicine and interventional oncology therapies, leveraging Northwestern’s clinical and engineering resources.
